Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate

NCT01857531 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Smoking Cessation

Interventions

DRUG: Ganaxolone
DRUG: Nicotine Patch

Sponsor

Jed E. Rose

Collaborators

[object Object]